Skip to main navigation
Genmab
  • Careers
  • Contact us
  • About Us
    • Company Overview
    • Strategy
    • Our Vision
    • Senior Leadership
    • Board of Directors
    • History
  • Product Pipeline
    • Products in development
      • Daratumumab
      • Ofatumumab
      • Tisotumab vedotin
      • Enapotamab vedotin (HuMax-AXL-ADC)
      • HexaBody-DR5/DR5
      • Epcoritamab (DuoBody-CD3xCD20)
      • DuoBody-PD-L1x4-1BB (GEN1046)
      • DuoBody-CD40x4-1BB (GEN1042)
      • DuoHexaBody-CD37 (GEN3009)
      • Teprotumumab
      • HuMax-IL8
      • Mim8
      • Camidanlumab tesirine
      • Amivantamab (JNJ-61186372)
      • JNJ-63709178
      • JNJ-67571244
      • JNJ-63898081
      • JNJ-64007957
      • JNJ-64407564
      • Lu AF82422
      • Pre-clinical
    • Clinical Trials
  • Research and Technology
    • Introduction to antibodies
    • Genmab antibody discovery
    • Genmab technology
  • Medical Affairs
  • Partnering
    • Our approach
    • Current partnerships
    • Licensing opportunities
      • Technology
  • Investors
    • Genmab News
    • Financial Reports
    • SEC Filings
    • Consolidated Key Figures
    • Stock Information
      • Analyst Coverage
      • Major Shareholders
      • Warrants
      • Restricted Stock Units
    • ADR Program
    • Events & Presentations
    • Financial Calendar
    • Annual General Meeting
    • Investor Portal
    • Corporate Governance
      • Articles of Association
      • Board Committees and Charters
      • Remuneration Principles
      • Code of Business Ethics
    • Corporate Social Responsibility
    • Email Alert Subscription
    • IR Policy
    • FAQ
    • Contact
  • Media
  • Contact Us
    • Office locations
    • Contact form
  • Careers
    • Our culture
    • Meet the team
    • Benefits
    • Current vacancies
  • Privacy
    • Applicants HR Genmab A/S
    • Applicants HR Genmab B.V.
    • Shareholders Genmab A/S
    • Annual General Meeting Genmab A/S
    • IR Subscriptions, Webcasts, Conference Calls
    • Clinical Trials
      • GCT1015-04
      • GCT1021-01
      • GCT1015-05
    • Website Inquiries and Website Use
  • Home >>
  • Investors >>
  • Corporate Governance >>
  • Articles of Association
  • Investors
  • Genmab News
  • Financial Reports
  • SEC Filings
  • Consolidated Key Figures
  • Stock Information
  • ADR Program
  • Events & Presentations
  • Financial Calendar
  • Annual General Meeting
  • InvestorPortal
  • Corporate Governance
    • Articles of Association
    • Remuneration Policy
    • Board Committees and Charters
    • Code of Business Conduct and Ethics
  • Corporate Social Responsibility
  • IR Policy
  • FAQ
  • Contact

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS News Feeds

Articles of Association

Articles of Association

Title View
Articles of Association - May 12, 2020 - Danish
Articles of Association - May 12, 2020 - Danish
Articles of Association - May 12, 2020 - English
Articles of Association - May 12, 2020 - English

Shareholder Tools

  • Email Alerts
  • Download Library
  • RSS News Feeds
  • Accessibility policy
  • Cookie policy
  • Disclaimer
  • Privacy
  • Sitemap
     
   
© 2020 Genmab A/S